Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksKainos Group Regulatory News (KNOS)

Share Price Information for Kainos Group (KNOS)

Share Price is delayed by 15 minutes
Get Live Data
787.00    11.50 (1.48%)
Bid:
789.50
Ask:
791.50
Spread: 2.00 (0.253%)
Market Cap: £906.42m
KNOS Live PriceLast checked at - London Stock Exchange

Intraday Kainos Group Share Chart

Director/PDMR Shareholding

5 Dec 2018 13:02

RNS Number : 5566J
Kainos Group plc
05 December 2018
 

5 December 2018

 

Kainos Group plc

 

("Kainos" or the "Company)

Director / PDMR shareholdings

The Company announces that on 4 December 2018, share awards (the "Awards") approved by the Board of Directors of the Company under the Company's HM Revenue and Customs approved Share Incentive Plan scheme (the "SIP Awards"), in the form of free ordinary shares, contingent on length of service of 0.5 pence each in the Company ("Ordinary Shares") were provided to all eligible U.K. based employees of the Company, including the executive directors of the Company, or its subsidiaries.

Application will be made for the 148,500 new Ordinary Shares to be admitted to the Official List of the UKLA and to trading on the London Stock Exchange's main market for listed securities.

 

 

Notification and public disclosure of transactions by persons discharging

managerial responsibilities and persons closely associated with them.

(A19 Market Abuse Regulation)

 

 

Kainos Group plc Legal Entity Identifier: 213800H2PQMIF3OVZY47 

 

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Brendan Mooney

2.

Reason for the notification

a.

Position/status

CEO

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

 

 

KNOS

b.

Nature of the transaction

SIP Share Awards 2018

c.

Price(s) and volume(s)

SIP Award1

Price(s)

Volume(s)

£4.23

400

 

1. Subject to the vesting criteria set out in the Annual Report.

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

04 December 2018

f.

Place of the transaction

Outside a Trading Venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Richard McCann

2.

Reason for the notification

a.

Position/status

CFO/COO

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

 

 

KNOS

b.

Nature of the transaction

SIP Share Awards 2018

c.

Price(s) and volume(s)

SIP Award1

Price(s)

Volume(s)

£4.23

460

 

1. Subject to the vesting criteria set out in the Annual Report.

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

04 December 2018

f.

Place of the transaction

Outside a Trading Venue

 

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

Paul Gannon

2.

Reason for the notification

a.

Position/status

Sales Director

b.

Initial notification

/Amendment

Initial

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Kainos Group plc

b.

LEI

213800H2PQMIF3OVZY47

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument/

type of instrument

Identification code

Ordinary Shares of £0.005 each

 

 

KNOS

b.

Nature of the transaction

RSS Share Awards 2018

c.

Price(s) and volume(s)

RSS Award1

Price(s)

Volume(s)

£4.23

460

 

1. Subject to the vesting criteria set out in the Annual Report. Mr Gannon's RSS shares are acquired through an Irish Revenue approved share scheme with similar provisions to the U.K. SIP.

d.

Aggregated information

· Aggregated volume

· Price

 

N/A

e.

Date of the transaction

04 December 2018

f.

Place of the transaction

Outside a Trading Venue

 

Ends

 

For further information, please contact:

 

Kainos via FTI Consulting LLP

Brendan Mooney, Chief Executive Officer

Richard McCann, Chief Financial Officer

 

Investec Bank plc +44 20 7597 5970

Patrick Robb / Sebastian Lawrence

 

Canaccord Genuity +44 20 7523 4606

Simon Bridges / Emma Gabriel

 

FTI Consulting LLP +44 20 3727 1000

Matt Dixon / Harry Staight

 

About Kainos

Kainos Group plc is a UK-based provider of Digital Services and Digital Platforms.

 

The Group's Digital Services include full lifecycle development and support of customised Digital Services for government and commercial customers. Kainos is also the leading European partner for Workday Inc. ('Workday') responsible for implementing Workday's innovative Software-as-a-Service (SaaS) platform for enterprise and, now, government customers.

 

The Group's Digital Platforms comprise specialised digital products in the mobile healthcare and automated testing arenas. Smart is an automated testing platform for Workday customers; Evolve Electronic Medical Records ('EMR') is the market leading product for the digitisation of patient notes in the Acute sector of the NHS; and Evolve Integrated Care ('IC') is a SaaS-based integrated care platform for the NHS and international healthcare providers.

 

Kainos has over 1,300 people across eleven offices in Europe and the USA, working interchangeably across its Services and Platforms divisions.

 

Kainos is listed on the London Stock Exchange (LSE: KNOS). For further information, please visit www.kainos.com

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHFKPDPBBDDCBK
Date   Source Headline
1st Apr 202511:18 amRNSTotal Voting Rights
1st Apr 20257:00 amRNSTransaction in Own Shares
31st Mar 20257:00 amRNSTransaction in Own Shares
28th Mar 20257:00 amRNSTransaction in Own Shares
27th Mar 20257:00 amRNSTransaction in Own Shares
26th Mar 20257:00 amRNSTransaction in Own Shares
25th Mar 20257:00 amRNSTransaction in Own Shares
24th Mar 20257:00 amRNSTransaction in Own Shares
21st Mar 20257:00 amRNSTransaction in Own Shares
20th Mar 20257:00 amRNSTransaction in Own Shares
19th Mar 20257:00 amRNSTransaction in Own Shares
18th Mar 20257:00 amRNSTransaction in Own Shares
17th Mar 20257:00 amRNSTransaction in Own Shares
14th Mar 20257:00 amRNSTransaction in Own Shares
13th Mar 20257:00 amRNSTransaction in Own Shares
12th Mar 20257:00 amRNSTransaction in Own Shares
11th Mar 20257:00 amRNSTransaction in Own Shares
10th Mar 20257:00 amRNSTransaction in Own Shares
7th Mar 20257:00 amRNSTransaction in Own Shares
6th Mar 20257:00 amRNSTransaction in Own Shares
5th Mar 20257:00 amRNSTransaction in Own Shares
4th Mar 20257:00 amRNSTransaction in Own Shares
3rd Mar 202511:19 amRNSTotal Voting Rights
3rd Mar 20257:00 amRNSTransaction in Own Shares
28th Feb 20257:00 amRNSTransaction in Own Shares
27th Feb 20257:00 amRNSTransaction in Own Shares
26th Feb 20257:00 amRNSTransaction in Own Shares
25th Feb 20257:00 amRNSTransaction in Own Shares
24th Feb 20257:00 amRNSTransaction in Own Shares
21st Feb 20257:00 amRNSTransaction in Own Shares
20th Feb 20257:00 amRNSTransaction in Own Shares
19th Feb 20257:00 amRNSTransaction in Own Shares
18th Feb 20257:00 amRNSTransaction in Own Shares
17th Feb 20257:00 amRNSTransaction in Own Shares
14th Feb 20257:00 amRNSTransaction in Own Shares
13th Feb 20257:00 amRNSTransaction in Own Shares
12th Feb 20257:00 amRNSTransaction in Own Shares
11th Feb 20257:00 amRNSTransaction in Own Shares
10th Feb 20257:00 amRNSTransaction in Own Shares
7th Feb 20257:00 amRNSTransaction in Own Shares
6th Feb 20257:00 amRNSTransaction in Own Shares
5th Feb 20257:00 amRNSTransaction in Own Shares
4th Feb 20257:00 amRNSTransaction in Own Shares
3rd Feb 20253:47 pmRNSTotal Voting Rights
3rd Feb 20257:00 amRNSTransaction in Own Shares
31st Jan 20257:00 amRNSTransaction in Own Shares
30th Jan 20257:00 amRNSTransaction in Own Shares
29th Jan 20257:00 amRNSTransaction in Own Shares
28th Jan 20257:00 amRNSTransaction in Own Shares
27th Jan 20257:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.